1. Home
  2. RNAZ vs SOWG Comparison

RNAZ vs SOWG Comparison

Compare RNAZ & SOWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • SOWG
  • Stock Information
  • Founded
  • RNAZ 2016
  • SOWG 2010
  • Country
  • RNAZ United States
  • SOWG United States
  • Employees
  • RNAZ N/A
  • SOWG N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • SOWG Packaged Foods
  • Sector
  • RNAZ Health Care
  • SOWG Consumer Staples
  • Exchange
  • RNAZ Nasdaq
  • SOWG Nasdaq
  • Market Cap
  • RNAZ 8.7M
  • SOWG 10.1M
  • IPO Year
  • RNAZ 2021
  • SOWG N/A
  • Fundamental
  • Price
  • RNAZ $14.80
  • SOWG $0.81
  • Analyst Decision
  • RNAZ Strong Buy
  • SOWG
  • Analyst Count
  • RNAZ 1
  • SOWG 0
  • Target Price
  • RNAZ $280.00
  • SOWG N/A
  • AVG Volume (30 Days)
  • RNAZ 387.0K
  • SOWG 958.1K
  • Earning Date
  • RNAZ 11-13-2025
  • SOWG 11-12-2025
  • Dividend Yield
  • RNAZ N/A
  • SOWG N/A
  • EPS Growth
  • RNAZ N/A
  • SOWG N/A
  • EPS
  • RNAZ N/A
  • SOWG N/A
  • Revenue
  • RNAZ N/A
  • SOWG $9,271,376.00
  • Revenue This Year
  • RNAZ N/A
  • SOWG $6.81
  • Revenue Next Year
  • RNAZ N/A
  • SOWG N/A
  • P/E Ratio
  • RNAZ N/A
  • SOWG N/A
  • Revenue Growth
  • RNAZ N/A
  • SOWG N/A
  • 52 Week Low
  • RNAZ $6.15
  • SOWG $0.51
  • 52 Week High
  • RNAZ $739.20
  • SOWG $11.34
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 84.37
  • SOWG 54.99
  • Support Level
  • RNAZ $10.32
  • SOWG $0.71
  • Resistance Level
  • RNAZ $12.28
  • SOWG $0.90
  • Average True Range (ATR)
  • RNAZ 0.87
  • SOWG 0.11
  • MACD
  • RNAZ 0.57
  • SOWG 0.00
  • Stochastic Oscillator
  • RNAZ 91.34
  • SOWG 29.30

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About SOWG Sow Good Inc. Common Stock

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.

Share on Social Networks: